Phase II study of 5-FU dose-adjusted mFOLFOX7 plus Bevacizumab for patients with metastatic colorectal cancer
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms A-JUST
- 01 Dec 2016 Status changed from active, no longer recruiting to completed as per results published in the Cancer Chemotherapy and Pharmacology.
- 01 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 09 Jun 2012 Additional lead investigator (Hideyuki Mishima) identified as reported by University Hospital Medical Information Network - Japan record.